Cargando…

HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA

Aggressive T and NK/T-cell lymphoma are known to have a high risk of relapse and poor long-term prognosis. Hematopoietic stem cell transplantation has been performed as part of consolidation or salvage treatment. We retrospectively studied the outcomes of autologous (A) and allogeneic (allo) hematop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng Kiat Ng, Lawrence, Shwei Wen Tham, Christopher, Wei Inng Lim, Francesca, Chen, Yunxin, Yeu Ong, Shin, Nagarajan, Chandramouli, Lee, Jing Jing, Tee Goh, Yeow, Linn, Yeh Ching, Shan Lee, Yuh, Diong Phipps, Colin, Kim Siang Quek, Jeffrey, Hein, Than, Cheng Hwang, Jordan Chung, Grigoropoulos, Nicholas, Khee Hwang, William Ying, Yew Leng Ho, Aloysius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia-Pacific Blood and Marrow Transplantation Group 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847283/ https://www.ncbi.nlm.nih.gov/pubmed/36714065 http://dx.doi.org/10.31547/bct-2021-007

Ejemplares similares

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
por: Ong, Shin-Yeu, et al.
Publicado: (2015)

Conjunctival T Cell Profile in Allogeneic Hematopoietic Stem Cell Transplant Patients after Instilling Topical Cyclosporine-A 0.1% Cationic Emulsion
por: Tong, Louis, et al.
Publicado: (2023)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2021)

A proposed predictive mathematical model for efficient T-cell collection by leukapheresis for manufacturing chimeric antigen receptor T cells
por: Huang, Xinxin, et al.
Publicado: (2023)

Real World Favourable Experience of Haematopoietic Stem Cell Transplantation during Acute Coronavirus Disease 2019 in a Highly-Vaccinated Asian Population
por: Tham, Christopher, et al.
Publicado: (2022)

Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies
por: Morita-Fujita, Mari, et al.
Publicado: (2020)

A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
por: Chen, Yunxin, et al.
Publicado: (2021)

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2020)

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma
por: Koviazin, Aleksei K., et al.
Publicado: (2023)

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
por: Kim, Seok Jin, et al.
Publicado: (2023)

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
por: Tay, Tricia, et al.
Publicado: (2022)

P1285: IMPROVING THE EFFECTIVENESS OF FIRST-LINE THERAPY FOR STAGE IV DIFFUSE LARGE B-CELL LYMPHOMA WITH UPFRONT AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION.
por: Koviazin, Aleksei, et al.
Publicado: (2023)

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
por: Li, Zhen, et al.
Publicado: (2023)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation
por: Tang, Andy Sing Ong, et al.
Publicado: (2023)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial
por: Kobayashi, Tsutomu, et al.
Publicado: (2022)

Stem cell transplant for mantle cell lymphoma in Taiwan
por: Wang, Yu-Hung, et al.
Publicado: (2022)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
por: Cho, Hyungwoo, et al.
Publicado: (2023)

Isolated Post-Transplantation Lymphoproliferative Disease Involving the Breast and Axilla as Peripheral T-cell Lymphoma
por: Hwang, Ji-Young, et al.
Publicado: (2013)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
por: Kizhakeyil, Atish, et al.
Publicado: (2021)

Optimizing Blood Stem Cell Transplants Through Cellular Engineering
por: Soh, Krystal Valerie Qian Ying, et al.
Publicado: (2022)

Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
por: Rashidi, A, et al.
Publicado: (2015)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
por: Dumont, Maëlle, et al.
Publicado: (2020)

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
por: Abeyakoon, Chathuri, et al.
Publicado: (2020)

Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas
por: Zhenyang, Gu, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Hosing, Chitra
Publicado: (2010)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
por: Mariotti, Jacopo, et al.
Publicado: (2020)

Stem cell transplant for lymphoma - never too late?
por: Cashen, Amanda F., et al.
Publicado: (2022)

Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell Transplantation
por: Bari, Sudipto, et al.
Publicado: (2019)

CAR T Cell Therapy in Hematological Malignancies: Implications of the Tumor Microenvironment and Biomarkers on Efficacy and Toxicity
por: Tan, Jing Yuan, et al.
Publicado: (2022)

Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma
por: Huang, Dachuan, et al.
Publicado: (2020)

Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
por: Reimer, Peter
Publicado: (2010)

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas
por: Paralkar, Vikram R., et al.
Publicado: (2011)

Autologous Peripheral Blood Hematopoietic Cell Transplantation in Dogs with T‐Cell Lymphoma
por: Warry, E.E., et al.
Publicado: (2014)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
por: Huang, Wen-Rong, et al.
Publicado: (2018)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019)

Economics of stem cell transplantation for lymphoma: counting the cost of living
por: Sweetenham, J W
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_vfhf2lar4gdhnnsl7o2u4k1ukt